C reactive protein impairs adaptive immunity in immune cells of patients with melanoma

Abstract

BackgroundHigh C reactive protein (CRP) levels have been reported to be associated with a poor clinical outcome in a number of malignancies and with programmed cell death protein 1 immune checkpoint blockade in patients with advanced cancer. Little is known about the direct effects of CRP on adaptive immunity in cancer. Therefore, we investigated how CRP impacted the function of T cells and dendritic cells (DCs) from patients with melanoma.MethodsThe effects of CRP on proliferation, function, gene expression and phenotype of patient T cells and DCs, and expansion of MART-1 antigen-specific T cells were analyzed by multicolor flow cytometry and RNA-seq. Additionally, serum CRP levels at baseline from patients with metastatic melanoma treated on the Checkmate-064 clinical trial were assessed by a Luminex assay.ResultsIn vitro, CRP inhibited proliferation, activation-associated phenotypes and the effector function of activated CD4+ and CD8+ T cells from patients with melanoma. CRP-treated T cells expressed high levels of interleukin-1β, which is known to enhance CRP production from the liver. CRP also suppressed formation of the immune synapse and inhibited early events in T-cell receptor engagement. In addition, CRP downregulated the expression of costimulatory molecules on mature DCs and suppressed expansion of MART-1-specific CD8+ T cells in a dose-dependent manner by impacting on both T cells and antigen-presenting cells. High-serum CRP levels at baseline were significantly associated with a shorter survival in both nivolumab-treated and ipilimumab-treated patients.ConclusionsThese findings suggest that high levels of CRP induce an immunosuppressivemilieuin melanoma and support the blockade of CRP as a therapeutic strategy to enhance immune checkpoint therapies in cancer.Trial registration numberNCT01783938andNCT02983006.

Serum interleukin-6 and C-reactive protein are associated with survival in melanoma patients receiving immune checkpoint inhibition

“…Baseline CRP was also associated with poor OS in both cohorts of Checkmate-064. 35 Open access Baseline N/L ratio was associated with survival in the Checkmate-066 and Checkmate-067 studies in a multivariable analysis and was highly correlated with IL-6 and CRP.…”

Prognostic implications of lymphocyte/C-reactive protein ratio with tumor-infiltrating lymphocytes in resected intrahepatic cholangiocarcinoma

“…Tumor in ltration by CD8 + T cells has been strongly associated with survival of cancer patients [26,28]. Yoshida et al also reported that CRP inhibited proliferation, activation, and function of CD8 + T cells in patients with melanoma [40]. Thus, CD8 + TILs may be more strongly associated with LCR, which is a robust prognostic factor.…”

Immunotoxic role of organophosphates: An unseen risk escalating SARS-CoV-2 pathogenicity

“…Alongside, ROS-mediated disruption of mitochondrial-membrane exposes cardiolipin and mtDNA to cytosol thus provoking NLRP3 to compose inflammasome ( Iyer et al, 2013 ). C-reactive proteins are elevated following OP exposure and higher levels of this inflammatory marker can contribute to immunosuppression ( Yoshida et al, 2020 ; Taghavian et al, 2016 ). IFN constitutes the first line of defense against viral infections ( Ivashkiv & Donlin, 2014 ).…”